LifeSpan Vision Ventures Invests in SENISCA
NORWALK, Conn., March 19, 2024 /PRNewswire/ — LifeSpan Vision Ventures, an investment firm specializing in longevity biotech investments, today announced an investment in SENISCA, an RNA therapeutics spinout from the University of Exeter. The company has developed proprietary technology that harnesses RNA biology to reprogram aged ‘senescent’ cells. Senescent cells behave differently to young, healthy […]